Overview
Support Groups
Latest News
Events
Clinical Trials
Aniridia
-
Jan 30, 2019 endigest.com
PTC Therapeutics, Inc. (PTCT) Reaches $29.68 After 4.00% Up Move; Clearfield Has 1.06 Sentiment – EN Digest
Read More -
Jan 30, 2019 portcourier.com
Intrexon Corporation (XON) and PTC Therapeutics Inc. (NASDAQ:PTCT) Comparison side by side – Port Courier
Read More -
Jan 28, 2019 www.upi.com
Stem cells motivate ocular surface repair in trial with vision loss patients – UPI News
Read More -
Jan 28, 2019 yomiblog.com
IntelliPharmaCeutics International Inc. (IPCI)’s Financial Results Comparing With PTC Therapeutics Inc. (NASDAQ:PTCT) – The Yomi Blog
Read More -
Jan 27, 2019 yomiblog.com
GlycoMimetics Inc. (GLYC)’s Financial Results Comparing With PTC Therapeutics Inc. (NASDAQ:PTCT) – The Yomi Blog
Read More -
Jan 27, 2019 finexaminer.com
Dana Investment Advisors Lowered Its Lam Research (LRCX) Position; PTC Therapeutics (PTCT) Sentiment Is 1.17 – The FinExaminer
Read More -
Jan 27, 2019 www.fairfieldcurrent.com
Comparing Obseva (OBSV) and PTC Therapeutics (PTCT) – Fairfield Current
Read More -
Jan 25, 2019 whatsonthorold.com
PTC Therapeutics Inc (NASDAQ:PTCT) Sentiment Report | Thorold News – Thorold News
Read More -
Jan 24, 2019 finreviewer.com
Reviewing Minerva Neurosciences Inc. (NERV)’s and PTC Therapeutics Inc. (NASDAQ:PTCT)’s results – The FinReviewer
Read More
